Clinical Trials@2x
  • News

    Most Read

    • Lilly’s bamlanivimab prevents Covid-19 at nursing homes in BLAZE-2 trial
    • Moderna begins dosing in Covid-19 vaccine study in Japan
    • Reify Health extends StudyTeam platform availability for clinical trials

    Most Recent

    Clinical Trials

    Lilly’s bamlanivimab prevents Covid-19 at nursing homes in BLAZE-2 trial

    22 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy
    • Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market
    • Novo Nordisk’s makes strides into Alzheimer’s with anti-diabetic drug

    Most Recent

    Clinical Trials

    Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy

    12 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • NIH reports full-dose blood thinners improve Covid-19 outcome
    • Adastra eyes CRO pitches for Phase II trial of anticancer candidate; initiates $45m Series B fundraising, exec says
    • Senhwa Biosciences initiates enrolment in Covid-19 drug trial

    Most Recent

    Clinical Trials

    NIH reports full-dose blood thinners improve Covid-19 outcome

    25 Jan 2021
  • Themes
  • Deals

    Most Read

    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink
    • IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea

    Most Recent

    Clinical Trials

    Investment firm GI Partners closes Clinical Ink acquisition

    27 Aug 2020
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Linari NanoTech
    • OpenClinica
    • Strategikon Pharma

    Most Recent

    Linari NanoTech

    19 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register

Companies seek to improve operational efficiency with digital transformation: Survey

The COVID-19 pandemic triggered unexpected challenges in the business environment prompting pharmaceutical companies to accelerate...

25th January 2021

COVID-19 pandemic led to increase in emerging technology investments in pharma, finds survey

The COVID-19 pandemic has led to an increase in investments in digital transformation and emerging...

25th January 2021
Adastra eyes CRO pitches for Phase II trial of anticancer candidate; initiates $45m Series B fundraising, exec says

Adastra eyes CRO pitches for Phase II trial of anticancer candidate; initiates $45m Series B fundraising, exec says

In addition, the company has initiated a $45m Series B round to finance the study...

25th January 2021
Orphazyme’s arimoclomol expected to be used with Zavesca after likely FDA approval in Niemann-Pick disease type C

Orphazyme’s arimoclomol expected to be used with Zavesca after likely FDA approval in Niemann-Pick disease type C

Orphazyme’s arimoclomol will likely be used alongside Johnson & Johnson’s Zavesca (miglustat) for most children...

22nd January 2021
NIH’s strategy to assess Moderna’s COVID-19 vaccine at half dose has significant stumbling blocks for evidence collection and analysis

NIH’s strategy to assess Moderna’s COVID-19 vaccine at half dose has significant stumbling blocks for evidence collection and analysis

The NIH’s proposal to use available data to investigate a half dose of Moderna’s authorised...

22nd January 2021
Lack of specific skills and talents one of the four top obstacles to digital transformation in companies: Survey

Lack of specific skills and talents one of the four top obstacles to digital transformation in companies: Survey

Digital transformation has become the need of the hour due to the COVID-19 pandemic. While...

22nd January 2021
Insufficient funding and legacy systems two of the top four obstacles to digital transformation: Survey

Insufficient funding and legacy systems two of the top four obstacles to digital transformation: Survey

Digital transformation is prodding the organisations to change the way things used to work and...

22nd January 2021
Lack of specific skills and talents main obstacle to digital transformation: Survey

Lack of specific skills and talents main obstacle to digital transformation: Survey

The shift towards digital technologies has been accelerated by the ongoing COVID-19 pandemic, which has...

21st January 2021
Pharmaceutical industry optimistic about the growth of digital transformation over the next 12 months: Survey

Pharmaceutical industry optimistic about the growth of digital transformation over the next 12 months: Survey

With the COVID-19 pandemic accelerating digital adoption, most of the organisations in the pharmaceutical industry...

21st January 2021
Mapi Pharma engages PRA Health Sciences as CRO for Phase III multiple sclerosis trial

Mapi Pharma engages PRA Health Sciences as CRO for Phase III multiple sclerosis trial

GA Depot is a long-acting version of Teva Pharmaceutical’s Copaxone (glatiramer acetate). Copaxone garnered its...

20th January 2021

Latest News

Clinical Trials

Montreal Heart Institute reports positive results from Covid-19 trial

25 Jan 2021
Technology

Telemedicine to benefit the most from remote patient monitoring tools: Poll

25 Jan 2021
Clinical Trials

NIH reports full-dose blood thinners improve Covid-19 outcome

25 Jan 2021
Clinical Trials

Senhwa Biosciences initiates enrolment in Covid-19 drug trial

25 Jan 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
CTArena_white-logo_

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more